ID

25762

Beschrijving

Study ID: 101468/207 Clinical Study ID: SKF-101468/207 Study Title:A double-blind, randomized, placebo-controlled, parallel-group study to investigate the tolerability of a dose-escalating regimen of ropinirole in patients suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome AE Section

Trefwoorden

Versies (1)
  1. 18-09-17 18-09-17 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

18 september 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC-ND 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

AE Section GSK Ropinirole Restless Legs Syndrome 101468

Engels

AE Section GSK Ropinirole Restless Legs Syndrome 101468

1 Formulieren  
Patient Information
Beschrijving

Patient Information

Alias
UMLS CUI-1
C1955348
Patient Number
Beschrijving

Patient Number

Datatype

text

Alias
UMLS CUI [1]
C1830427
Centre Number
Beschrijving

Centre Number

Datatype

text

Alias
UMLS CUI [1,1]
C0600091
UMLS CUI [1,2]
C0019994
Adverse Event - Please note any SERIOUS events should NOT be recorded on this page, but on the SERIOUS ADVERSE EVENT pages provided. Record any Adverse event (using standard medical terminology) observed or elicited as a result of spontaneous reporting by patient 'How are you feeling' (pre-dose) and at subsequent schedules intervals post dose: 'Since you were last asked have you felt unwell or different from usual?'
Beschrijving

Adverse Event - Please note any SERIOUS events should NOT be recorded on this page, but on the SERIOUS ADVERSE EVENT pages provided. Record any Adverse event (using standard medical terminology) observed or elicited as a result of spontaneous reporting by patient 'How are you feeling' (pre-dose) and at subsequent schedules intervals post dose: 'Since you were last asked have you felt unwell or different from usual?'

Alias
UMLS CUI-1
C0877248
If no adverse events, please mark box and sign form below.
Beschrijving

Adverse Event

Datatype

boolean

Alias
UMLS CUI [1]
C0877248
Adverse Event
Beschrijving

Adverse Event: Specification

Datatype

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C2348235
Onset Date
Beschrijving

Onset Date

Datatype

date

Maateenheden
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0574845
dd-mmm-yyyy
Onset Time
Beschrijving

Onset Time

Datatype

time

Maateenheden
  • 24hr:min
Alias
UMLS CUI [1]
C0449244
24hr:min
End Date (If ongoing, please leave blank)
Beschrijving

End Date

Datatype

date

Maateenheden
  • dd-mmm-yyyy
Alias
UMLS CUI [1]
C0806020
dd-mmm-yyyy
End Time (If ongoing, please leave blank)
Beschrijving

End Time

Datatype

time

Maateenheden
  • 24hr:min
Alias
UMLS CUI [1]
C1522314
24hr:min
Outcome
Beschrijving

Adverse Event Outcome

Datatype

text

Alias
UMLS CUI [1]
C1705586
Event Course
Beschrijving

Event Course

Datatype

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0750729
Event Course If Intermittent, specify No. of episodes
Beschrijving

Number of Episodes

Datatype

float

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C4086638
Intensity (maximum)
Beschrijving

Intensity

Datatype

text

Action Taken with Respect to Investigational Drug
Beschrijving

Action Taken

Datatype

text

Alias
UMLS CUI [1]
C2826626
Relationship to Investigational Drug
Beschrijving

Relationship

Datatype

text

Alias
UMLS CUI [1]
C0439849
Corrective Therapy. If 'YES', please record on Concomitant Medication form.
Beschrijving

Corrective Therapy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0087111
Was subject due to this AE?
Beschrijving

Withdrawal due to Adverse Event

Datatype

boolean

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1519255
Date
Beschrijving

Adverse Event Date

Datatype

date

Alias
UMLS CUI [1]
C2697888
Terug naar het begin van de pagina

Similar models

AE Section GSK Ropinirole Restless Legs Syndrome 101468

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Patient Information
C1955348 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Centre Number
Item
Centre Number
text
C0600091 (UMLS CUI [1,1])
C0019994 (UMLS CUI [1,2])
Item Group
Adverse Event - Please note any SERIOUS events should NOT be recorded on this page, but on the SERIOUS ADVERSE EVENT pages provided. Record any Adverse event (using standard medical terminology) observed or elicited as a result of spontaneous reporting by patient 'How are you feeling' (pre-dose) and at subsequent schedules intervals post dose: 'Since you were last asked have you felt unwell or different from usual?'
C0877248 (UMLS CUI-1)
Adverse Event
Item
If no adverse events, please mark box and sign form below.
boolean
C0877248 (UMLS CUI [1])
Adverse Event: Specification
Item
Adverse Event
text
C0877248 (UMLS CUI [1,1])
C2348235 (UMLS CUI [1,2])
Onset Date
Item
Onset Date
date
C0574845 (UMLS CUI [1])
Onset Time
Item
Onset Time
time
C0449244 (UMLS CUI [1])
End Date
Item
End Date (If ongoing, please leave blank)
date
C0806020 (UMLS CUI [1])
End Time
Item
End Time (If ongoing, please leave blank)
time
C1522314 (UMLS CUI [1])
Item
Outcome
text
C1705586 (UMLS CUI [1])
Adverse Event Outcome
Code List
Outcome
CL Item
Resolved (Resolved)
CL Item
Ongoing (Ongoing)
Item
Event Course
text
C0877248 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
Event Course
Code List
Event Course
CL Item
Intermittent (Intermittent)
CL Item
Constant (Constant)
Number of Episodes
Item
Event Course If Intermittent, specify No. of episodes
float
C0877248 (UMLS CUI [1,1])
C4086638 (UMLS CUI [1,2])
Item
Intensity (maximum)
text
Intensity
Code List
Intensity (maximum)
CL Item
Mild (Mild)
CL Item
Moderate (Moderate)
CL Item
Severe (Severe)
Item
Action Taken with Respect to Investigational Drug
text
C2826626 (UMLS CUI [1])
Action Taken
Code List
Action Taken with Respect to Investigational Drug
CL Item
Non (Non)
CL Item
Dose reduced (Dose reduced)
CL Item
Dose increased (Dose increased)
CL Item
Drug interrupted/restarted (Drug interrupted/restarted)
CL Item
Drug stopped (Drug stopped)
Item
Relationship to Investigational Drug
text
C0439849 (UMLS CUI [1])
Relationship
Code List
Relationship to Investigational Drug
CL Item
Related (Related)
CL Item
Possibly related (Possibly related)
CL Item
Probably related (Probably related)
CL Item
Unrelated (Unrelated)
Corrective Therapy
Item
Corrective Therapy. If 'YES', please record on Concomitant Medication form.
boolean
C0877248 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Withdrawal due to Adverse Event
Item
Was subject due to this AE?
boolean
C2349954 (UMLS CUI [1,1])
C1519255 (UMLS CUI [1,2])
Adverse Event Date
Item
Date
date
C2697888 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial